Cann Group teams up with Emyria to develop pharmacy grade CBD capsules

Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria ...

Restricted content. Do you want to read more?